Skip to product information
1 of 1

NSJ Bioreagents

SKU:F42277-0.05ML

Anti-MDM2 Antibody

Anti-MDM2 Antibody

Regular price $205.00 USD
Regular price Sale price $205.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

MDM2 is a target of the transcription factor tumor protein p53. The encoded protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of MDM2 can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. This protein also affects the cell cycle,apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5.

Specifications

Family Primary antibody
Formulation In 1X PBS, pH 7.4, with 0.09% sodium azide
Format Purified
Host Animal Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Species Reactivity Human, Mouse
Application WB, IHC, ELISA
Application Details Western blot: 1:1000,IHC (Paraffin): 1:10-1:50
Application Note Titration of the anti-MDM2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Immunogen A portion of amino acids 393-424 from the human protein was used as the immunogen for this anti-MDM2 antibody.
Purity Purified
Storage Aliquot the anti-MDM2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This anti-MDM2 antibody is available for research use only.
Uniprot # Q00987
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/anti-mdm2-antibody-f42277
Title Anti-MDM2 Antibody
Description MDM2 is a target of the transcription factor tumor protein p53. The encoded protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of MDM2 can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. This protein also affects the cell cycle,apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5.
View full details